Ethiopia National Guidelines for TB, DR-TB and Leprosy - Sixth Edition

Oct 6, 2026

Uploaded by Riley

National guidelines for managing tuberculosis (TB), drug-resistant TB (DR-TB), and leprosy in Ethiopia, Sixth Edition (November 2017), set out governmental commitment and updated national strategies. The foreword describes TB’s global burden, Ethiopia’s high-incidence context, and the impact of drug-resistant TB and HIV co-infection. It outlines targets aligned with the End TB strategy, emphasizing robust case finding, rapid diagnostics, equitable services, and research and innovations to reduce deaths, cut incidence, and prevent catastrophic household expenses.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages217

Reading Time9 h 7 min

AccessFree to download

Foreword

Background and burden of TB, DR-TB, and leprosy

Ethiopia’s commitments and End TB targets

Acknowledgement

Revision consultations and contributors

Acronyms

GUIDELINES FOR MANAGEMENT OF TB, DR-TB AND LEPROSY IN ETHIOPIA SIXTH EDITION November 2017 Addis Ababa NATIONAL GUIDELINES FOR TB, DR-TB AND LEPROSY IN ETHIOPIA FOREWORD Tuberculosis (TB) is a major public health problem throughout the world by infecting an estimated one-third of the world’s population and putting them at risk of developing active disease during their lifetime. Tuberculosis is the leading cause of deaths every year among the infectious disease worldwide alongside HIV. It kills more than five thousand children, women and men each day. According to the Global TB Report 2017, 10.6 million people are estimated to have fallen ill with TB in 2016 while an estimated 1.3 million people died of TB. In addition, an estimated 4. 1% of these new TB cases and 19% of the previously treated cases are believed to harbour Drug resistant-TB with an estimated 240 000 deaths annually due to Drug resistant-TB. Ethiopia is among the 30 High TB, HIV and MDR-TB Burden Countries, with annual estimated TB incidence of 177/100,000 populations and death rate of 25 per 100,000 populations for 2016. Among the notified TB cases in 2016, 2.7%) of new TB cases and 14% among previously treated TB cases were also estimated to harbour drug resistant TB. Ethiopia has notified 125,836 new TB cases and enrolled 702 drug-resistant TB casein 2016. Although the majority of TB cases has affected the productive age group, 15 100 (12%) cases were reported among children aged under 15 year. HIV co-infection impedes the TB control efforts contributing to around 8% of annually notified TB cases. Ethiopia has successfully achieved the millennium development goals set for TB in 2015. The country’s has expressed its commitment to accelerate the fight to end TB epidemic by 2035 by endorsing the new post-2015 Global “END TB strategy” and has already aligned the National TB Strategic Plan within the framework of National Health Sector Transformation Plan. The National End TB strategy aims to end the TB epidemic by reducing TB related deaths by 95% and by cutting incident TB cases by 90% between 2015 and 2035; and to ensure that no family is burdened with catastrophic expenses due to TB. The strategy calls for use of robust TB case finding strategies and use of rapid diagnostic technologies to address the gap in finding the missed TB cases and threat of Drug resistant TB. The program is committed to improve access and equitable TB services to vulnerable and marginalized population groups where TB burden concentrates and most delays happen due to socio-economic and legal barriers. The program has also recognized the need for research and innovations to sharply bend the TB epidemic curve to meet the ambitious targets for 2035. This guideline expresses the strong governmental commitment by introducing the most up-to-date National strategies, recommendations, clinical and programmatic NATIONAL GUIDELINES FOR TB, DR-TB AND LEPROSY IN ETHIOPIA practices towards provision of patient-centered quality TB/DR-TB care. The national leprosy control strategy, programmatic recommendations and clinical care guidance is also provided in separate section. Finally, I would like to call all actors of Tuberculosis in the country to actively engage in their concerted efforts towards ending the TB epidemic by 2020 in Ethiopia to achieve universal health coverage for all segments of the population as in the country’s transformation plan to join the middle income countries. Kebede Worku MD, MPH State minister of Health, FDRE NATIONAL GUIDELINES FOR TB, DR-TB AND LEPROSY IN ETHIOPIA ACKNOWLEDGEMENT The revision process of this sixth edition of national guideline has undergone multiple consultations and continuous involvement of experts on TB, DR-TB, TB/HIV and Leprosy(see annex 1 for the list of contributors) . I would like to acknowledge experts working at the National TB control program for their outstanding contributions and coordination effor

FAQs

What is the purpose of the Ethiopia national guidelines on TB, DR-TB, and leprosy?

The guideline presents up-to-date national strategies, recommendations, and clinical and programmatic practices for patient-centered quality TB/DR-TB care, and it includes separate leprosy control strategy and guidance sections.

What targets does the End TB strategy set for 2015–2035?

It aims to reduce TB-related deaths by 95% and cut incident TB cases by 90% between 2015 and 2035, while ensuring no family is burdened with catastrophic expenses due to TB.

Which approaches does the guideline highlight to address missed TB cases and drug-resistant TB threats?

It calls for robust TB case finding strategies and the use of rapid diagnostic technologies to reduce missed cases and respond to the threat of drug-resistant TB.

Oct 6, 2026

Uploaded by Riley